Cargando…
MDM2 SNP309 rs2279744 Polymorphism and Gastric Cancer Risk: A Meta-Analysis
BACKGROUND: MDM2 is a major negative regulator of p53, and a single nucleotide polymorphism (SNP) in the MDM2 promoter region SNP309 has been demonstrated to be associated with an increased MDM2 expression and a significantly earlier age of onset of several tumors, including gastric cancer. Several...
Autores principales: | Ma, Yong, Bian, Jianmin, Cao, Hongyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581579/ https://www.ncbi.nlm.nih.gov/pubmed/23451111 http://dx.doi.org/10.1371/journal.pone.0056918 |
Ejemplares similares
-
Association between MDM2 rs2279744, MDM2 rs937283, and p21 rs1801270 polymorphisms and retinoblastoma susceptibility
por: Cao, Qixin, et al.
Publicado: (2018) -
MDM2 SNP309 polymorphism is associated with colorectal cancer risk
por: Wang, Weizhi, et al.
Publicado: (2014) -
Associations of MDM2 rs2279744 and TP53 rs1042522 polymorphisms with cervical cancer risk: A meta-analysis and systematic review
por: Yu, Meijia, et al.
Publicado: (2022) -
An Updated Meta-Analysis on the Association of MDM2 SNP309 Polymorphism with Colorectal Cancer Risk
por: Qin, Xue, et al.
Publicado: (2013) -
The cell cycle regulatory gene polymorphisms TP53 (rs1042522)
and MDM2 (rs2279744) in lung cancer: a meta-analysis
por: Bulgakova, O., et al.
Publicado: (2020)